Your clinician should explain both the benefits of GLP-1 therapyincluding improved glycaemic control, weight loss, and cardiovascular protectionand the theoretical risks based on animal data
Lillys tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution
adults at an estimated cost of $132 billion per year
As a physician for hundreds of affected patients, I launched a Change.org petition that has already drawn over 16,000 signatures, urging Caremark to rethink their decision
But, Ipamorelin has high releasing potency and effectiveness, increasing growth hormone levels by 20 to 30 times their base level, and inhibiting somatostatinor, the growth inhibiting hormone